The present study is therefore aimed at investigating the prevalence of hepatic alterations (laboratory and imaging) in adult patients with TS and generating hypothesissto the possible etiopathogenetic factors most involved, as well as evaluating the correlation between biochemical and structural abnormalities.
Thus, the study could provide relevant etiopathogenetic and prognostic results on the development of hepatopathy in TS patients.
Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.
Age 18 years or older
Written informed consent obtained
TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).